Inovio Pharmaceuticals, Inc. (INO)
1.305
-0.06
(-4.04%)
USD |
NASDAQ |
May 15, 16:00
1.33
+0.02
(+1.92%)
After-Hours: 18:49
Inovio Pharmaceuticals Total Liabilities (Quarterly) : 43.71M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| ADMA Biologics, Inc. | 274.86M |
| Agenus, Inc. | 414.44M |
| Vaxart, Inc. | 85.94M |
| Capricor Therapeutics, Inc. | 47.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 49.78M |
| Shareholders Equity (Quarterly) | 6.068M |
| Debt to Equity Ratio | 1.433 |
| Current Ratio | 1.04 |
| Net Debt Paydown Yield | 0.52% |